PharmacyCodes



Betazolum [Inn-Latin] en es it fr

Betazolum [Inn-Latin] Brand names, Betazolum [Inn-Latin] Analogs

Betazolum [Inn-Latin] Brand Names Mixture

  • No information avaliable

Betazolum [Inn-Latin] Chemical_Formula

C5H9N3

Betazolum [Inn-Latin] RX_link

No information avaliable

Betazolum [Inn-Latin] fda sheet

Betazolum [Inn-Latin] msds (material safety sheet)

Betazolum [Inn-Latin] Synthesis Reference

No information avaliable

Betazolum [Inn-Latin] Molecular Weight

111.145 g/mol

Betazolum [Inn-Latin] Melting Point

< 25 oC

Betazolum [Inn-Latin] H2O Solubility

No information avaliable

Betazolum [Inn-Latin] State

Liquid

Betazolum [Inn-Latin] LogP

0.069

Betazolum [Inn-Latin] Dosage Forms

Injection

Betazolum [Inn-Latin] Indication

For use clinically to test gastric secretory function.

Betazolum [Inn-Latin] Pharmacology

Betazole is a histamine H2 agonist used in a test for measuring maximal production of gastric acidity or anacidity. This measurement can be used to diagnose diseases such as Zollinger-Ellison syndrome, whereby the volume of gastric and basal secretions is measured following betazole administration (greater than 60% of the maximal acid secretion following betazole stimulation). In another test, gastritis can be diagnosed given late absence of gastric acid which is unresponsive to betazole stimulation. Betazole can be used as a gastric secretory stimulant instead of histamine with the advantage of not provoking side effects and thus not requiring the use of antihistaminic compounds.

Betazolum [Inn-Latin] Absorption

Rapid and complete.

Betazolum [Inn-Latin] side effects and Toxicity

No information avaliable

Betazolum [Inn-Latin] Patient Information

No information avaliable

Betazolum [Inn-Latin] Organisms Affected

Humans and other mammals